Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Metabolic disorders » Prevalence
 

Prevalence and Incidence of Metabolic disorders

Prevalance of types of Metabolic disorders:

For details see prevalence of types of Metabolic disorders analysis; summary of available prevalence data:

  • Diabetes: 16 million Americans with 10.3 million diagnosed and 8.1 million women (NWHIC); 65 per 1000 - NHIS95; 8 million - perhaps 16 million if include not-yet-diagnosed.
  • Metabolic syndrome: about 25% of the USA population have insulin resistance
  • High Cholesterol: estimated 101 million Americans have cholesterol >= 200 mg/dL (CDC)
  • Heterozygous Familial Hypercholesterolemia: 1 per 500 US people suffer from Heterozygous familial hypercholesterolemia.
  • Osteoporosis: 28 million Americans (10 million with osteoporosis; 18 million with low bone mass); eight million American women and 2 million men (NWHIC)
  • Paget's disease of bone: about 3% of people aged over 40; 10% by age 80.
  • Homozygous Familial Hypercholesterolemia: 1 per 1 million US people suffer from Homozygous familial hypercholesterolemia.
  • Wilson's Disease: approximately 1 per 30,000 people suffer from Wilson disease, Genetics Home Reference website
  • Adrenoleukodystrophy: 1 per 20,000 people suffer from X-linked adrenoleukodystrophy, Genetics Home reference website
  • Lactose Intolerance: 30 million people to 50 million people (NIDDK 1994); about 25% of population (1994/NIDDK)
  • Alkaptonuria: 1 per 19,000 people suffer from alkaptonuria in parts of Slovakia, Genetics Home Reference website
  • Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency: 1 per 40,000 - 120,000 people suffer from very long-chain acyl-CoA dehydrogenase deficiency, Genetics Home Reference website
  • Medium-Chain Acyl-CoA Dehydrogenase Deficiency: 1 per 17,000 people suffer from medium-chain acyl-CoA dehydrogenase deficiency in the US, Genetics Home Reference website
  • Glutathione Synthetase Deficiency: only about 70 cases of glutathione synthetase deficiency have been reported worldwide, Genetics Home Reference website
  • Cystinuria: approximately 1 per 10,000 people are affected by cystinuria, Genetics Home Reference website
  • HMG-CoA lyase deficiency: less than 100 people have been diagnosed with HMG-CoA lyase deficiency worldwide, Genetics Home Reference website
  • Gaucher disease type 1: 1 per 500 - 1,000 people of Ashkenazi Jewish heritage are affected by type 1 Gaucher disease, Genetics Home Reference website
  • Gaucher disease type 2: less than 1 per 500,000 births are affected by Gaucher disease type 2, Genetics Home Reference website
  • Gaucher disease type 3: less than 1 per 100,000 births are affected by Gaucher disease type 3, Genetics Home Reference website
  • GM2-gangliosidosis, AB variant: only a few cases of GM2-gangliosidosis, AB variant reported worldwide, Genetics Home Reference website
  • Homocystinuria: at least 1 per 200,000 - 335,000 people are affected by homocystinuria worldwide, Genetics Home Reference website
  • Galactosemia I: 1 per 30,000 liver births are affected by inherited galactosemia, Genetics Home Reference website
  • Acidemia, methylmalonic: estimated 1 per 50,000 - 100,000 suffer from Methylmalonic acidemia, Genetics Home Reference website
  • Amyloidosis: less than 3,000 people in the US (Mayo Clinic)
  • Niemann-Pick disease, type A: approximately 1 per 40,000 people of Ashkenazi Jewish descent have Niemann-Pick disease type A, Genetics Home Reference website
  • Niemann-Pick disease, type C2: approximately 1 per 150,000 people have Niemann-Pick disease type C, Genetics Home Reference website
  • Beta ketothiolase deficiency: 50 - 60 cases of beta-ketothiolase deficiency have been reported worldwide, Genetics Home Reference website
  • Maple syrup urine disease: estimated 1 per 385 infants suffer from maple syrup urine disease in the Old Order Mennonite population, Genetics Home Reference website
  • $2-methylglutaconic aciduria type 3$: 1 per 10,000 newborns from Iraqi Jewish populations suffer from 2-methylglutaconic aciduria type 3, Genetics Home Reference website
  • $3-methylglutaconic aciduria, type 1$: less than 20 cases of 2-methylglutaconic aciduria type 1 have been reported, Genetics Home Reference website
  • Barth Syndrome: 1 per 200,000 male infants suffer from 2-methylglutaconic aciduria type 2, Genetics Home Reference website
  • Zellweger Syndrome: rare
  • Phenylketonuria: 1 per 10,000 - 15,000 newborns are diagnosed with phenylketonuria in the US, Genetics Home Reference website
  • Kearns-Sayre Syndrome: rare
  • Abetalipoproteinemia: only about 100 cases of abetalipoproteinemia reported worldwide, Genetics Home Reference website
  • Mucopolysaccharidosis type I Hurler-Scheie syndrome: about 200 people ("Orphan Products: Hope for People With Rare Diseases", By Carol Rados, FDA Consumer magazine, November-December 2003 Issue)
  • Pompe disease: 1 per 40,000 people suffer from Pompe disease, Genetics Home Reference website
  • Ethylmalonic aciduria: about 30 cases of ethylmalonic encephalopathy have been reported worldwide, Genetics Home Reference website
  • Malonic aciduria: less than 20 cases of malonic aciduria have been reported, Genetics Home Reference website
  • Glutaricaciduria I: estimated 1 per 300 people from the Ojibwa population of Canada suffer from glutaric academia type I, Genetics Home Reference website
  • Pyruvate carboxylase deficiency: estimated 1 per 250,000 births are affected by pyruvate carboxylase deficiency, Genetics Home Reference website
  • Isovaleric academia: 1 per 250,000 births are affected by isovaleric academia in the US, Genetics Home Reference website
  • Propionic academia: estimated 1 per 100,000 live births suffer from propionic academia in the US, Genetics Home Reference website
  • Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency: estimated 1 per 62,000 people suffer from long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency in Finland, Genetics Home Reference website
  • Carnitine palmitoyl transferase 1 deficiency: less than 50 people suffer from Jervell and Lange-Nielsen syndrome worldwide, Genetics Home Reference website
  • Arginase deficiency: estimated 1 per 300,000 - 1,000,000 people suffer from arginase deficiency, Genetics Home Reference website
  • Carnitine palmitoyl transferase II deficiency, lethal neonatal form: the lethal neonatal form of carnitine palitoyl transferase II deficiency has been reported in 10 families, Genetics Home Reference website
  • Hemochromatosis: more than 1 million Americans (CDC); 5 per 1000 in Caucasians (NIDDK); 1-in-200 to 1-in-300
  • Hemochromatosis type 1: 1 million people suffer from hemochromatosis type 1 in the US, Genetics Home Reference website
  • Holocarboxylase synthetase deficiency: estimated 1 per 87,000 people are affected by holocarboxylase synthetase deficiency, Genetics Home Reference website
  • Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: estimated less than 100 people have been reportd with ornithine translocase deficiency worldwide, Genetics Home Reference website
  • Carnitine-acylcarnitine translocase deficiency: about 30 cases of carnitine-acylcarnitine translocase deficiency have been confirmed, Genetics Home Reference website
  • Citrullinemia II: 1 per 100,000 - 230,000 people have citrullinemia II in Japan , Genetics Home Reference website
  • $3-methylcrotonyl-CoA carboxylase deficiency$: estimated 1 per 50,000 people suffer from 3-methylcrotonyl-CoA carboxylase deficiency, Genetics Home Reference website
  • Carnitine palmitoyl transferase II deficiency, infantile hepatocardiomuscular type: the infantile hepatocardiomusucular form of carnitine palmitoyl transferase II deficiency has been reported in 10 families, Genetics Home Reference website
  • Carbamoyl-phosphate synthase 1 deficiency: estimated 1 per 800,000 newborns suffer from carbamoyl phosphate synthetase I deficiency in Japan, Genetics Home Reference website
  • Biotinidase deficiency: about 1 per 60,000 newborns suffer from profound or partial biotinidase deficiency, Genetics Home Reference website
  • Tyrosinemia, type III: only a few cases of tyrosinemia type III have been reported, Genetics Home Reference website
  • N-acetyl glutamate synthetase deficiency: only a few cases of N-acetylglutamate synthase deficiency have been reported worldwide, Genetics Home Reference website
  • Carnitine transporter deficiency: 1 per 40,000 newborns suffer from primary carnitine deficiency in Japan, Genetics Home Reference website
  • Ornithine transcarbamylase (OTC) Deficiency: estimated 1 per 80,000 people suffer fro ornithine transcarbamylase deficiency, Genetics Home Reference website
  • $2-methylbutyryl-coenzyme A dehydrogenase deficiency$: 1 per 250 - 500 people from Hmong populations in southeast Asia and America suffer from 2-methylbutyryl-coenzyme A dehydrogenase deficiency though many are asymptomatic, Genetics Home Reference website
  • Citrullinemia I: 1 per 57,000 people have citrullinemia I worldwide , Genetics Home Reference website
  • Krabbe leukodystrophy: 1 per 100,000 people are affected by Krabbe disease in the US, Genetics Home Reference website
  • Glucose-6-Phosphate Dehydrogenase Deficiency: 1 in 10 African-American males suffer from glucose-6-phosphate dehydrogenase deficiency in the US, Genetics Home Reference website
  • Short-Chain Acyl-CoA Dehydrogenase Deficiency: 1 per 40,000 - 100, 000 newborns suffer from short-chain acyl-CoA dehydrogenase deficiency in the US, Genetics Home Reference website
  • Gaucher Disease: 1 per 50,000 - 100,000 people are affected by Gaucher disease, Genetics Home Reference website
  • Fabry's Disease: rare
  • Krabbé Disease: rare
  • Isobutyryl-coenzyme A dehydrogenase deficiency: less than 5 cases of isobutyryl-coenzyme A dehydrogenase deficiency have been reported, Genetics Home Reference website
  • Familial hyperchylomicronemia: 1 per 1 million suffer from familial lipoprotein lipase deficiency worldwide, Genetics Home Reference website
  • Hepatorenal tyrosinemia: 1 per 1,846 people from the Saguenay-La St. Jean region of Quebec suffer from tyrosinemia type 1, Genetics Home Reference website
  • Oculocutaneous tyrosinemia: 1 per 250,000 people suffer from tyrosinemia type 2, Genetics Home Reference website
  • Variegate porphyria: approximately 3 per 1,000 white South Africans suffer from variegate porphyria, Genetics Home Reference website
  • Porphyria cutanea tarda, familial type: 1-2 per 100,000 people are affected by porphyria cutanea tarda, Genetics Home Reference website
  • Congenital adrenal hyperplasia -- non-classical form: nonclassical 21-hydroxylase deficiency occurs in an estimated 1 in 100 people, Genetics Home Reference
  • Fahr's Syndrome: rare
  • Menkes Disease: estimated 1 per 100,000 people suffer Menkes syndrome, Genetics Home Reference website
  • Hypokalemic periodic paralysis: 1 per 100,000 people suffer from hypokalemic periodic paralysis, Genetics Home Reference website
  • Hyperkalemic periodic paralysis: 1 per 200,000 people are affected by hyperkalemic periodic paralysis, Genetics Home Reference website
  • Sandhoff Disease: rare
  • Lesch-Nyhan syndrome: 1 per 380,000 people are affected by Lesch-Nyhan syndrome worldwide, Genetics Home Reference website
  • Tangier disease: about 50 cases of Tangier disease have been diagnosed worldwide, Genetics Home Reference website
  • Tetrahydrobiopterin Deficiency: 30% of infants born with high phenylalanine levels have tetrahydrobiopterin deficiency in China, Genetics Home Reference website
  • Alpha 1-Antitrypsin Deficiency: 1 per 5,000 - 7,000 people suffer from alpha-1 antitrypsin deficiency in North America, Genetics Home Reference website
  • Smith-Lemli-Opitz Syndrome: estimated 1 per 20,000 - 40,000 newborns suffer from Smith-Lemli-Opitz syndrome, Genetics Home Reference website
  • Cystinosis: 1 per 26,000 newborns suffer from cystinosis in the Brittany province in France, Genetics Home Reference website
  • Pantothenate kinase-associated neurodegeneration: estimated 1-3 per 1 million people are affected by Hallervorden-Spatz disease worldwide, Genetics Home Reference website
  • Myositis ossificans: estimated 1 per 2 million people are affected by fibrodysplasia ossificans progressiva, Genetics Home Reference website
  • Oxalosis, type I: estimated 1 per 60,000 - 120,000 births are affected by primary hyperoxaluria, type I, Genetics Home Reference website
  • Gaucher-like disease: only a few cases of Gaucher-like disease have been reported worldwide, Genetics Home Reference website
  • more types of Metabolic disorders...»

Incidence of types of Metabolic disorders:

For details see incidence of types of Metabolic disorders analysis; summary of available incidence by type data:

More Statistics about Metabolic disorders:

  • Hospitalization statistics
  • Cost statistics
  • All statistics for Metabolic disorders

    About prevalence and incidence statistics:

    The term 'prevalence' of Metabolic disorders usually refers to the estimated population of people who are managing Metabolic disorders at any given time. The term 'incidence' of Metabolic disorders refers to the annual diagnosis rate, or the number of new cases of Metabolic disorders diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.

  •  

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise